Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
9.64
-0.23 (-2.33%)
At close: Jul 15, 2026, 4:00 PM EDT
9.51
-0.13 (-1.35%)
After-hours: Jul 15, 2026, 7:38 PM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $706.33 million as of July 15, 2026. Its market cap has increased by 161.78% in one year.
Market Cap
706.33M
Enterprise Value
560.76M
1-Year Change
161.78%
Ranking
Category
Stock Price
$9.64
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $706.33M, an increase of 217.61%. That is a compound annual growth rate of 26.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 706.33M | 127.72% |
| Dec 31, 2025 | 310.18M | -15.87% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | 222.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omeros | 744.02M |
| Gyre Therapeutics | 726.91M |
| REGENXBIO | 721.20M |
| Monopar Therapeutics | 714.09M |
| Allogene Therapeutics | 690.31M |
| Prime Medicine | 682.73M |
| Relmada Therapeutics | 672.35M |
| BridgeBio Oncology Therapeutics | 666.49M |